137 related articles for article (PubMed ID: 7200161)
1. Hemodynamic effects of prostaglandin E1 during cardiopulmonary bypass in infants and children.
Kawamura M; Minamikawa O; Yokochi H; Maki S; Yasuda T; Mizukawa Y
Jpn J Surg; 1982; 12(1):19-25. PubMed ID: 7200161
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.
Karliczek G; van den Dungen JJ; Brenken U; Eijsman L; Kootstra GJ; Homan van der Heide JN; Wildevuur CR
Thorac Cardiovasc Surg; 1981 Feb; 29(1):55-9. PubMed ID: 6164120
[TBL] [Abstract][Full Text] [Related]
3. The effect of prostaglandin E1 in patients undergoing clinical cardiopulmonary bypass.
van den Dungen JJ; Karliczek GF; Brenken U; van der Heide JN; Wildevuur CR
Ann Thorac Surg; 1983 Apr; 35(4):406-14. PubMed ID: 6682305
[TBL] [Abstract][Full Text] [Related]
4. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
Okuda M; Faruhashi K; Konishi K; Muneyuki M
Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
[TBL] [Abstract][Full Text] [Related]
5. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children.
Mossad E; Motta P; Sehmbey K; Toscana D
J Clin Anesth; 2008 Mar; 20(2):94-8. PubMed ID: 18410862
[TBL] [Abstract][Full Text] [Related]
6. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
[TBL] [Abstract][Full Text] [Related]
7. [Effects of prostaglandin E1 infusion during cardiopulmonary bypass].
Okuda M; Ohi Y; Utsunomiya H; Kurata M; Konishi K; Muneyuki M
Masui; 1989 Aug; 38(8):1036-41. PubMed ID: 2810697
[TBL] [Abstract][Full Text] [Related]
8. Platelet-anti-aggregating and hemodynamic effects of adenosine and prostaglandin E1.
Masters TN; Born GV; Robicsek F
Thorac Cardiovasc Surg; 1982 Feb; 30(1):14-20. PubMed ID: 6179225
[No Abstract] [Full Text] [Related]
9. Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension.
Weesner KM
Cathet Cardiovasc Diagn; 1991 Sep; 24(1):10-5. PubMed ID: 1913785
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery.
Rubis LJ; Stephenson LW; Johnston MR; Nagaraj S; Edmunds LH
Ann Thorac Surg; 1981 Dec; 32(6):563-70. PubMed ID: 7198428
[TBL] [Abstract][Full Text] [Related]
11. [The effects of prostaglandin E1 on systemic and cerebral oxygenation before and during cardiopulmonary bypass].
Kawahara F; Kadoi Y
Masui; 2002 Feb; 51(2):128-33. PubMed ID: 11889777
[TBL] [Abstract][Full Text] [Related]
12. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
13. [Effects of prostaglandin E1 and dibutyryl cyclic AMP on hemodynamics after cardiopulmonary bypass in valve replacement surgery].
Sumiyoshi N; Kawachi S; Oishi K; Tsushima K; Nakatani T; Imanishi T; Matsuda M; Hirose T; Tagami D
Masui; 1992 Apr; 41(4):532-8. PubMed ID: 1315879
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
Pan S; Xiao M; Liu Y
Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure.
Popat KD; Pitt B
Am Heart J; 1982 Apr; 103(4 Pt 1):485-9. PubMed ID: 7199815
[TBL] [Abstract][Full Text] [Related]
16. Depressed pulmonary removal of [3H]prostaglandin E1 after prolonged cardiopulmonary bypass.
Pitt BR; Hammond GL; Gillis CN
J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):887-92. PubMed ID: 7200970
[TBL] [Abstract][Full Text] [Related]
17. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
Naeije R; Mélot C; Mols P; Hallemans R
Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypoxia on the hemodynamic actions of prostaglandin E1.
Alpert JS; Beller GA; Giamber SR; Saltz SB
Prostaglandins; 1976 May; 11(5):783-97. PubMed ID: 935511
[TBL] [Abstract][Full Text] [Related]
19. [The effects of prostaglandin E1 infusion during cardiopulmonary bypass on cardiac and renal function in the early postoperative period].
Sato K; Ebine K; Tamura S; Yokomuro M; Suzuki H; Kumabe S; Okuda T; Ootsuki M; Kosakai K
Nihon Kyobu Geka Gakkai Zasshi; 1994 Mar; 42(3):360-5. PubMed ID: 8176292
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
